Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer
- 27 April 2009
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 100 (1), 38-42
- https://doi.org/10.1002/jso.21294
Abstract
Background Few studies have investigated the Glasgow Prognostic Score (GPS) in patients with liver metastases from colorectal cancer (LM‐CRC). Methods The GPS was calculated as follows: patients with both an elevated level of CRP (>10 mg/L) and hypoalbuminemia (Alb P < 0.0001). Univariate analysis revealed that sex, number of hepatectomy, number of tumors, synchronous lung metastasis and CRP were associated with postoperative death. Multivariate analysis revealed that number of hepatectomy (odds ratio, 3.193; 95% CI, 1.093–9.330; P = 0.0338), number of tumors (odds ratio, 2.946; 95% CI, 1.094–7.931; P = 0.0325), synchronous lung metastasis (odds ratio, 3.424; 95% CI, 1.055–11.11; P = 0.0404) and CRP (odds ratio, 4.509; 95% CI, 1.313–15.49; P = 0.0167) were associated with postoperative death. Conclusions GPS is able to classify patients with LM‐CRC into three independent groups. Among the selected factors, CRP is considered an important and high sensitive predictor of postoperative death in such patients. J. Surg. Oncol. 2009;100:38–42.Keywords
This publication has 31 references indexed in Scilit:
- Inflammation-Based Prognostic Score Is a Novel Predictor of Postoperative Outcome in Patients With Colorectal CancerAnnals of Surgery, 2007
- C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastasesBritish Journal of Cancer, 2007
- Evaluation of an inflammation‐based prognostic score in patients with metastatic renal cancerCancer, 2007
- Elevated tumour interleukin-1β is associated with systemic inflammation: a marker of reduced survival in gastro-oesophageal cancerBritish Journal of Cancer, 2006
- Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancerBritish Journal of Cancer, 2006
- First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly scheduleAnnals of Oncology, 2004
- Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by ChemotherapyAnnals of Surgery, 2004
- Elevation of preoperative serum C‐reactive protein level is related to poor prognosis in esophageal squamous cell carcinomaJournal of Surgical Oncology, 2003
- Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastasesBritish Journal of Surgery, 2003
- Inflammation and cancerNature, 2002